Financial & Business

Surgicure Technologies Attracts $1.78 Million in Seed Funding

Money fuels development of life-saving innovation to replace outdated airway securing methods.

By: Michael Barbella

Managing Editor

Photo: Business Wire.

Surgicure Technologies Inc. has closed a $1.785 million seed funding round led by Launchpad Venture Group (LVG) that will help the company commercialize its flagship product, the Horseshoe.

Founded in 2019 by Irena King, Surgicure Technologies aims to reduce adverse events in airway management by introducing devices that optimize patient breathing and streamline clinical workflows. Originally invented by army respiratory therapists and now re-designed by King, the Horseshoe is a patented solution for more reliable ET tube securement, facial pressure injury prevention, and better oral care. The technology not only improves clinical outcomes but also offers cost savings and device versatility in critical care, burn/trauma scenarios, and during evacuation or transport.

“This investment marks a transformative moment for Surgicure Technologies,” said King, Surgicure Technologies’ founder and CEO. “The industry is poised for disruption as the current practices for securing life-sustaining breathing tubes often rely on flimsy tape, leading to potential complications such as cardiac arrest, brain damage, and a 30% rate of preventable deaths. Our solution is designed to tackle these challenges head-on, driving substantial improvements in patient outcomes.”

In addition to LVG, Surgicure Technologies received major contributions from Gurtin Ventures, BakerBridge Capital, TiE Angels, SBXi, Beacon Angels, SideCar Angels, Tidal River Fund and BBE Ventures.

“At Launchpad Venture Group, we are thrilled to lead Surgicure’s oversubscribed Series Seed round and support their efforts to bring innovative, patient-specific surgical solutions to market,” LVG Managing Director Ian Levine stated. “Surgicure’s technology addresses critical unmet medical needs, including preventing unintended and accidental extubations—a serious and preventable cause of complications and mortality. We believe Surgicure has the potential to set a new standard of care, and we are excited to partner with their talented team to help make that vision a reality.”

Surgicure Technologies is a medical device company specializing in airway management tools for both civilian and military applications. Its technology enables healthcare professionals to enhance patient outcomes by reducing adverse events; the firm’s solutions are designed to optimize breathing support, accelerate deployment, and elevate patient care safety and quality, ensuring better results in critical situations.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters